“Certolizumab Pegol for the Treatment of Patients With Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S3, https://doi.org/10.25251/skin.2.supp.3.